Abstract
Ventilated preterm infants prone to the development of bronchopulmonary dysplasia have been shown to have increased inflammatory mediators in their tracheal aspirates. High frequency oscillatory ventilation (HFOV) is thought to be less traumatic than intermittent positive pressure ventilation (IPPV) in premature infants with surfactant deficiency, and therefore may reduce the inflammatory response in tracheobronchial aspirates. We randomized 76 premature infants requiring mechanical ventilation (birth weight 420-1830 g, median 840 g, gestational age 23 3/7 to 29 2/7 wk, median 26 4/7 to receive either an IPPV with a high rate (60-80/min) and low peak pressures, or an HFOV aiming at an optimization of lung volume, within 1 h of intubation. Tracheal aspirates were systematically collected during the first 10 d of life and analyzed for albumin, IL-8, leukotriene B4 (LTB4), and the secretory component (SC) for IgA as a reference protein. Bacterially colonized samples were excluded. On the treatment d 1, 3, 5, 7, and 10, the resulting median values of albumin (milligrams/mg of SC) were 28, 23, 24, 18, and 10, in IPPV-ventilated infants, and 33, 28, 18, 25, and 39 in HFOV-ventilated infants, respectively. Median IL-8 values (nanograms/mg of SC) were 671, 736, 705, 1362, and 1879 (IPPV) and 874, 1713, 1029, 1426, and 1823 (HFOV), respectively, and median LTB4 values (nanograms/mg of SC) were 26, 13, 27, 22, and 11 (IPPV) and 15, 12, 7, 12, and 16 (HFOV), respectively. Values were similar in IPPV- and HFOV-ventilated infants, and no significant differences were noted. We conclude that HFOV, when compared with a high rate low pressure IPPV, does not reduce concentrations of albumin, IL-8, and LTB4 in tracheal aspirates of preterm infants requiring mechanical ventilation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- BPD:
-
bronchopulmonary dysplasia
- TA:
-
tracheal aspirate
- LTB4:
-
leukotriene B4
- HFOV:
-
high frequency oscillatory ventilation
- IPPV:
-
intermittent positive pressure ventilation
- MAP:
-
mean airway pressure
- PIP:
-
peek inspiratory pressure
- PIE:
-
pulmonary interstitial emphysema
- HFJV:
-
high frequency jet ventilation
- PaO2:
-
partial pressure of arterial O2
- PaCO2:
-
partial pressure of arterial CO2
- FIO2:
-
fractional concentration of inspired CO2
- SC:
-
secretory component for IgA
References
Egberts J, Brand R, Walti H, Bevilacqua G, Bréart G, Gardini F 1997 Mortality, severe respiratory distress syndrome, and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf. Pediatrics 100e: 4
Groneck P, Speer CP 1995 Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child 73: F1 F3
Kotecha S 1996 Cytokines in chronic lung disease of prematurity. Eur J Pediatr 155( suppl 2): S14 S17
Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ 1995 Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child 72: F90–F96 .
Murch SH, Costeloe K, Klein NJ, MacDonald TT 1996 Early production of macrophage inflammatory protein-1 alpha occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res 40: 490–497.
Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ 1996 Increase in interleukin (IL)-1β and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 40: 250–256.
Little S, Dean T, Bevin S, Hall M, Ashton M, Church M, Warner J, Shute J 1995 Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants. Thorax 50: 1073–1079.
Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD 1994 Increased activity of interleukin-6 but not tumor necrosis factor-α in lung lavage of premature infants in associated with the development of bronchopulmonary dysplasia. Pediatr Res 36: 244–252.
Groneck P, Goetze-Speer B, Oppermann M, Eiffert H, Speer CP 1994 Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 93: 712–718.
Donnelly SC, Strieter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, Grant IS, Pollok AJ, Haslett C 1993 Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups. Lancet 341: 643–647.
Groeneveld AB, Raijmakers PG, Hack CE, Thijs LG 1995 Interleukin 8-related neutrophil elastase and the severity of the adult respiratory distress syndrome. Cytokine 7: 746–752.
Watts CL, Bruce MC 1992 Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia. J Pediatr 121: 597–607.
Groneck P, Oppermann M, Speer CP 1993 Levels of complement anaphylatoxin C5a in pulmonary effluent fluid of infants at risk for chronic lung disease and effects of dexamethasone treatment. Pediatr Res 34: 586–590.
Groneck P, Reuss D, Goetze-Speer B, Speer CP 1993 Effects of dexamethasone on chemotactic activity and inflammatory mediators in tracheobronchial aspirates of pretern infants at risk for chronic lung disease. J Pediatr 122: 938–944.
McCulloch PR, Forkert PG, Froese AB 1988 Lung volume maintenance prevents lung injury during high frequency oscillatory ventilation in surfactant-deficient rabbits. Am Rev Respir Dis 137: 1185–1192.
Froese AB, McCulloch PR, Sugiura M, Vaclavik S, Possmayer F, Moller F 1993 Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit. Am Rev Respir Dis 148: 569–577.
De Lemos RA, Coalson JJ, Gerstmann DR, Null Jr DM, Ackerman NB, Escobedo MB, Robotham JL, Kuehl TJ 1987 Ventilatory management of infant baboons with hyaline membrane disease: the use of high frequency ventilation. Pediatr Res 21: 594–602.
DeLemos RA, Coalson JJ, Meredith KS, Gerstmann DR, Null DM 1989 A comparison of ventilation strategies for the use of high-frequency oscillatory ventilation in the treatment of hyaline membrane disease. Acta Anaesth Scand Suppl 90: 102–107.
Coalson JJ, De Lemos RA 1989 Pathologic features of various ventilatory strategies. Acta Anaesth Scand Suppl 90: 108–116.
Jackson JC, Truog WE, Standaert TA, Murphy JH, Juul SE, Chi EY, Hildebrandt J, Hodson WA 1994 Reduction in lung injury after combined surfactant and high-frequency ventilation. Am J Respir Crit Care Med 150: 534–539.
Jackson JC, Truog WE, Standaert TA, Juul SE, Murphy JH, Chi EY, Mackenzie AP, Hodson WA 1991 Effect of high-frequency ventilation on the development of alveolar edema in premature monkeys at risk for hyaline membrane disease. Am Rev Respir Dis 143: 865–871.
Solimano A, Bryan C, Jobe A, Ikegami M, Jacobs H 1985 Effects of high-frequency and conventional ventilation on the premature lamb lung. J Appl Physiol 59: 1571–1577.
HIFI Study Group 1989 1989 High-frequency oscillatory ventilation compared with conventional mechanical ventilation in the treatment of respiratory failure in preterm infants. N Engl J Med 320: 88–93.
Ogawa Y, Miyasaka K, Kawano T, Imura S, Inukai K, Okuyama K, Oguchi K, Togari H, Nishida H, Mishina J 1993 A multicenter randomized trial of high frequency oscillatory ventilation as compared with conventional mechanical ventilation in preterm infants with respiratory failure, Early Hum D. Early Hum Dev 32: 1–10.
The HiFO Study Group 1993 Randomized study of high-frequency oscillatory ventilation in infants with severe respiratory distress syndrome. J Pediatr 122: 609–619.
Clark RH, Gerstmann DR, Null J, Prospective randomized comparison of high-frequency oscillatory and conventional ventilation in respiratory distress syndrome. Pediatrics 89: 5–12.
Gerstmann DR, Minton SD, Stoddard RA, Meredith KS, Monaco F, Bertrand JM, Battisti O, Langhendries JP, Francois A, Clark RH 1996 The Provo multicenter early high-frequency oscillatory ventilation trial: improved pulmonary and clinical outcome in respiratory distress syndrome. Pediatrics 98: 1044–1057.
Clark RH, Gerstmann DR 1998 Controversies in high-frequency ventilation. Clin Perinatol 25: 113–122.
Pohlandt F, Saule H, Schroeder H, Leonhardt A, Hoernchen H, Wolff C, Bernsau U, Oppermann HC, Obladen M, Feilen KD 1992 Decreased incidence of extra-alveolar air leakage or death prior to air leakage in high versus low rate positive pressure ventilation: results of a randomised seven-centre trial in preterm infants. Eur J Pediatr 151: 904–909.
Oxford region controlled trial of artificial ventilation (OCTAVE) study group 1991 Multicentre randomised controlled trial of high against low frequency positive pressure ventilation. Arch Dis Child 66: 770–775.
Heicher DA, Kasting DS, Harrod JR 1981 Prospective clinical comparison of two methods for mechanical ventilation of neonates: rapid rate and short inspiratory time versus slow rate and long inspiratory time. J Pediatr 98: 957–961.
Bryan AC, Froese AB 1991 Reflections on the HIFI trial. Pediatrics 87: 565–567.
Watts CL, Bruce MC 1995 Comparison of secretory component for immunoglobulin A with albumin as reference proteins in tracheal aspirate from preterm infants. J Pediatr 127: 113–122.
Tan ND, Davidson D 1995 Comparative differences and combined effects of interleukin-8, leukotriene B4, and platelet-activating factor on neutrophil chemotaxis of the newborn. Pediatr Res 38: 11–16.
Hallman M, Merritt TA, Jarvenpaa AL, Boynton B, Mannino F, Gluck L, Moore T, Edwards D 1985 Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr 106: 963–969.
Groneck P, Goetze-Speer B, Speer CP 1996 Inflammatory bronchopulmonary response sponse of preterm infants with microbial colonisation of the airways at birth. Arch Dis Child 74:F51–F55.
Watts CL, Fanaroff AA, Bruce MC 1992 Elevation of fibronectin levels in lung secretions of infants with respiratory distress syndrome and development of bronchopulmonary dysplasia. J Pediatr 120: 614–620.
Swischuk LE 1977 Bubbles in hyaline membrane disease. Differentation of three types. Radiology 122: 417–426.
Nelson NM 1996 J'accuse!-M. LeComte de LaPlace a Prohibe le Recrutement des Alveoles du Poumon (Can high-frequency ventilation conscript alveolar recruits and encourage re-enlistment?) [Comment]. Pediatrics 98: 1196–1197.
Thome U, Pohlandt F 1998 Effect of the TI/TE ratio on mean intratracheal pressure in high frequency oscillatory ventilation. J Appl Physiol 84: 1520–1527.
Froese AB 1991 Mechanical ventilation. In: Cernick V, Mellins RB (eds) Basic Mechanisms of Pediatric Respiratory Disease: Cellular and Integrative. BC Decker, Philadelphia, 418–431.
Clark RH 1994 High-frequency ventilation. J Pediatr 124: 661–670.
Walsh MC, Carlo WA 1988 Sustained inflation during HFOV improves pulmonary mechanics and oxygenation. J Appl Physiol 65: 368–372.
Bhuta T, Henderson-Smart DJ 1997 Elective high-frequency oscillatory ventilation versus conventional ventilation in preterm infants with pulmonary dysfunction: systemic review and meta-analyses. Pediatrics 100e: 6
Keszler M, Modanlou HD, Brudno DS, Clark FI, Cohen RS, Ryan RM, Kaneta MK, Davis JM 1997 Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome. Pediatrics 100: 593–599.
McCain RW, Holden EP, Blackwell T, Christman JW 1993 Leukotriene B4 stimulates human polymorphonuclear leucocytes to produce interleukin-8. Am Rev Respir Dis 147:A754.
Baggiolini M, Walz A, Kunkel SL 1989 Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84: 1045–1049.
Bussolino F, Sironi M, Bocchietto E, Mantovani A 1992 Synthesis of platelet-activating factor by polymorphonuclear neutrophils stimulated with interleukin-8. J Biol Chem 267: 14598–14603.
Thomsen MK, Larsen CG, Thomsen HK, Kirstein D, Skak-Nielsen T, Ahnfelt-Ronne I, Thestrup-Pedersen K 1991 Recombinant human interleukin-8 is a potent activator of canine neutrophil aggregation, migration, and leukotriene B4 biosynthesis. J Invest Dermatol 96: 260–266.
Martin TR, Raugi G, Merritt TL, Henderson WR Jr 1987 Relative contribution of leukotriene B4 to the neutrophil chemotactic activity produced by the resident human alveolar macrophage. J Clin Invest 80: 1114–1124.
Burgess CA, McCandless BK, Cooper JA, Malik AB 1990 Leukotriene B4 increases pulmonary transvascular filtration by a neutrophil-independent mechanism. J Appl Physiol 68: 1260–1264.
Rindfleisch MS, Hasday JD, Taciak V, Broderick K, Viscardi RM 1996 Potential role of interleukin-1 in the development of bronchopulmonary dysplasia. J Interferon Cytokine Res 16: 365–373.
Rozycki HJ 1994 Bronchoalveolar interleukin-1 beta in infants on day 1 of life. South Med J 87: 991–996.
Kari MA, Raivio KO, Venge P, Hallman M 1994 Dexamethasone treatment of infants at risk for chronic lung disease: surfactant components and inflammatory parameters in airway specimens. Pediatr Res 36: 387–393.
Biffl WL, Moore EE, Moore FA, Carl VS, Kim FJ, Franciose RJ 1994 Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch Surg 129: 1131–1136.
Meredith KS, deLemos RA, Coalson JJ, King RJ, Gerstmann DR, Kumar R, Kuehl TJ, Winter DC, Taylor A, Clark RH, Null DM Jr 1989 Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons. J Appl Physiol 66: 2150–2158.
Imai Y, Kawano T, Miyasaka K, Takata M, Imai T, Okuyama K 1994 Inflammatory chemical mediators during conventional ventilation and during high frequency oscillatory ventilation. Am J Respir Crit Care Med 150: 1550–1554.
Sugiura M, McCulloch PR, Wren S, Dawson RH, Froese AB 1994 Ventilator pattern influences neutrophil influx and activation in atelectasis-prone rabbit lung. J Appl Physiol 77: 1355–1365.
Nagase T, Fukuchi Y, Shimizu T, Matsuse T, Orimo H 1990 Reduction of 15-hydroxyeicosatetraenoic acid (15-HETE) in tracheal fluid by high frequency oscillatory ventilation. Prostaglandins Leukot Essent Fatty Acids 40: 177–180.
Troug WE, Jackson JC, Standaert TA, Juul SE, Murphy JH, Hodson WA, Henderson WR 1991 Acute changes in vasoactive lipid mediators in experimental hyaline membrane disease. Respir Physiol 90: 363–375.
Acknowledgements
The authors thank J. Tröger and H. C. Oppermann for reading the chest radiographs, J. Högel for statistical advice, S. Schmid for maintaining the database, and R. J. Kopotic for reviewing the manuscript.
Author information
Authors and Affiliations
Additional information
Supported by funds from the Deutsche Forschungsgemeinschaft, Project No. Th 626/1-1, and HFV ventilators from Nellcor Puritan Bennett Inc.
Presented in part at the European Society for Pediatric Research-Meeting 1997 in Szeged/Hungary.
Rights and permissions
About this article
Cite this article
Thome, U., Götze-Speer, B., Speer, C. et al. Comparison of Pulmonary Inflammatory Mediators in Preterm Infants Treated with Intermittent Positive Pressure Ventilation or High Frequency Oscillatory Ventilation . Pediatr Res 44, 330–337 (1998). https://doi.org/10.1203/00006450-199809000-00011
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-199809000-00011
This article is cited by
-
Comparable effect of conventional ventilation versus early high-frequency oscillation on serum CC16 and IL-6 levels in preterm neonates
Journal of Perinatology (2011)
-
Pulmonary inflammation and bronchopulmonary dysplasia
Journal of Perinatology (2006)
-
HFOV in premature neonates: effects on pulmonary mechanics and epithelial lining fluid cytokines. A randomized controlled trial
Intensive Care Medicine (2005)
-
Early use of high frequency ventilation in the premature neonate
European Journal of Pediatrics (2003)
